[1]MATSSUOKA T,YASHIRO M.Novel biomarkers for early detection of gastric cancer[J].World J Gastroenterol,2023,29(17):2515-2533.
[2]ILGIZ GAREEV,AAMIR AHMAD,WANG JQ,et al.Gastric juice non-coding RNAs as potential biomarkers for gastric cancer[J].Front Physiol,2023,14:1179582.
[3]LAHOUD RM,O' SHEA A,EL-MOUHAYYAR C,et al.Tumour markers and their utility in imaging of abdominal and pelvic malignancies[J].Clin Radiol,2021,6(2):99-107.
[4]BOSCH X,MOLINA R,MARRADES R,et al.Tumour markers with clinically controlled cut-offs for suspected cancer[J].Eur J Clin Invest,2021,51(7):e13523.
[5]JELSKI W,MROCZKO B.Molecular and circulating biomarkers of gastric cancer[J].Int J Mol Sci,2022,23(14):7588-7601.
[6]MURRAY MJ,SCARPINI CG,COLEMAN N.Serum tumour markers for testicular cancer recurrence[J].Nat Rev Urol,2023,20(8):459-460.
[7]徐宏勇,徐立,李开宗.一种新型胃肠道癌特异性单链抗体的表达及其在胃癌中的检测[J].胃肠病学和肝病学杂志,2011,20(8):754-757.
XU HY,XU L,LI KZ.Expression of a new scFv directed towards gastrointestinal carcinoma[J].Chin J Gastroentrol Heptol,2011,20(8):754-757.
[8]BUMBAT M,WANG M,LIANG W,et al.Effects of Me2SO and trehalose on the cell viability,proliferation,and Bcl-2 family gene(BCL-2,BAX,and BAD) expression in cryopreserved human breast cancer cells[J].Biopreserv Biobank,2020,18(1):33-40.
[9]KALONI D,DIEPSTRATEN ST,STRASSRE A,et al.BCL-2 protein family:Attractive targets for cancer therapy[J].Apoptosis,2023,28(1-2):20-38.
[10]ΖHANG Y,YANG X,GE X,et al.Puerarin attenuates neurological deficits via Bcl-2/Bax/cleaved caspase-3 and Sirt3/SOD2 apoptotic pathways in subarachnoid hemorrhage mice[J].Biomed Pharmacother,2019,109(1):726-733.
[11]徐立,徐宏勇,樊代明.胃肠道肿瘤靶向抗癌胚抗原单链抗体与T细胞表面受体基因的融合分子构建[J].中华消化杂志, 2004,24(2):75-77.
XU L,XU HY,FAN DM.Constructing a fusion molecular with T cell receptor for activaton of carcinoembryonic actigen specific cytotoxic T lymphocytes to gastrointestinal tumors[J].Chin J Dig,2004,24(2):75-77.
[12]MR 格林,J 萨姆布鲁克.分子克隆实验指南[M].贺福初译.第4版.北京:科学出版社,2017:938-946.
MR GREEN, J SAM BROOKER.The condensed protocols from molecular coning:A laboratory manual[M].HE FC translate.4th edition.Beijing:Science Publishing House,2017:938-946.
[13]徐宏勇,徐立.一种特异性靶向性淋巴细胞对荷瘤裸鼠的治疗观察[J].中国普外基础与临床杂志,2018,25(3):283-288.
XU HY,XU L.Obsevation of therapy a new specific cytotoxic T lymphocytes towards tumor bearing nude mice[J].Chin J Bases Clin General Surg,2018,25(3):283-288.
[14]SCHLUCK M,HAMMINK R,FIGDOR CG,et al.Biomaterial-based activation and expansion of tumor-specific T cells[J].Front Immunol,2019,10(3):931-942.
[15]KUMARI S,DHAPOLA R,REDDY DH.Apoptosis in Alzheimer's disease:Insight into the signaling pathways and therapeutic avenues[J].Apoptosis,2023,28(7-8):943-957.
[16]KUPCHO K,SHULTZ J,HURST R,et al.A real-time,bioluminescent annexin V assay for the assessment of apoptosis[J].Apoptosis,2019,24(1-2):184-197.
[17]KUMAR S,FAIRMICHAEL C,LONGLEY DB,et al.The multiple roles of the IAP super-family in cancer[J].Pharmacol Ther,2020,214:107610.
[18]LI Q,ZHANG W.Progress in anticancer drug development targeting ubiquitination-related factors[J].Int J Mol Sci,2022,23(23):15104-15119.
[19]SHARMA VK,SINGH TG,SINGH S,et al.Apoptotic pathways and Alzheimer's disease:Probing therapeutic potential[J].Neurochem Res,2021,46(12):3103-3122.
[20]KHODAVIRDIPOUR A,JAMSHIDI F,NEJAD HR,et al.To study the anti-cancer effects of shigella flexneri in AspC-1 pancreatic cancer cell line in approach to Bax and Bcl-2 genes[J].J Gastrointest Cancer,2021,52(2):593-599.
[21]RATATAJCZAK K,GLATZEL-PLUCINSKA N,RATAJCZAK B,et al.Effect of resveratrol treatment on human pancreatic cancer cells through alterations of Bcl-2 family members[J].Molecules,2021,26(21):6560.
[22]EL-SAWY ER,EL-SHAHID ZA,SOLIMAN AAF,et al.Synthetic analogs of marine alkaloid aplysinopsin suppress anti-apoptotic protein BCL2 in prostate cancer[J].Molecules,2022,28(1):109-126.
[23]BRINKMANN K,NG AP,DE GRAAF CA,et al.What can we learn from mice lacking pro-survival BCL-2 proteins to advance BH3 mimetic drugs for cancer therapy[J].Cell Death Differ,2022,29(6):1079-1093.
[24]COSENTINO K,HERTLEIN V,JENNER A,et al.The interplay between BAX and BAK tunes apoptotic pore growth to control mitochondrial-DNA-mediated inflammation[J].Mol Cell,2022,82(5):933-949.
[25]LI M,WANG D,HE J,et al.Bcl-XL:A multifunctional anti-apoptotic protein[J].Pharmacol Res,2020,151(1):104547.
[26]HOFFMEISTER-WITTMANN P,MOCK A,NICHETTI F,et al.Bcl-xL as prognostic marker and potential therapeutic target in cholangiocarcinoma[J].Liver Int,2022,42(12):2855-2870.
[27]SCIMECA M,ROVELLA V,PALUMBOL V,et al.Programmed cell death pathways in cholangiocarcinoma:Opportunities for targeted therapy[J].Cancers(Basel),2023,15(14):3638-3668.